Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case
Neuropathology and Applied Neurobiology · 2026
DOI: 10.1111/nan.70091 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropathology and Applied Neurobiology, 2026. Verfasst von Tadashi Adachi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuropathology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Cell Cycle Proteins, Ubiquitins. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
We report on the clinicopathological and biochemical features at autopsy of a patient with familial amyotrophic lateral sclerosis carrying an Ubiquilin2 (UBQLN2) P494L mutation. Neuropathologically, there were widespread TDP‐43‐positive inclusions in the whole brain, especially upper and lower motor neurons, limbic systems and hippocampus; Ubiquilin2‐positive intranuclear inclusions were also present. Biochemically, the UBQLN2 mutation patient showed TDP‐43 Type B inclusions and decreased UBQLN2 expression. These findings support the hypothesis that loss of function of UQBLN2 is linked to the formation of TDP‐43 inclusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuropathology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan.
- Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan.
- Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
- Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
ORCID-Profile: Tadashi Adachi, Kentaro Yoshida, Norikazu Hara, Takeshi Ikeuchi
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Adachi, T., Nakano, T., Yoshida, K., Suzuki, Y., Sakuwa, M., Hasegawa, M., Jannah, A. R., Hara, N., Miyashita, A., Ikeuchi, T., & Hanajima, R. (2026). Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.70091
Vancouver
Adachi T, Nakano T, Yoshida K, Suzuki Y, Sakuwa M, Hasegawa M, et al. Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case. Neuropathology and Applied Neurobiology. 2026. doi:10.1111/nan.70091
BibTeX
@article{Adachi2026,
author = {Adachi, Tadashi and Nakano, Toshiya and Yoshida, Kentaro and Suzuki, Yuki and Sakuwa, Mayuko and Hasegawa, Masato and Jannah, Alfi Raudatil and Hara, Norikazu and Miyashita, Akinori and Ikeuchi, Takeshi and Hanajima, Ritsuko},
title = {Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case},
journal = {Neuropathology and Applied Neurobiology},
year = {2026},
doi = {10.1111/nan.70091}
}
EUVIMED